Bernstein Upgrades Biogen On 'Compelling' Pipeline, Stock Now Undervalued

By: via Benzinga
In a report published Monday, Bernstein analyst Geoffrey C. Porges upgraded the rating on Biogen Inc (NASDAQ: BIIB) from Market-Perform ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.